Ablexis and AlivaMab Services Announce Expansion of Antibody Drug Discovery
14 Nov 2022 //
BUSINESSWIRE
AlivaMab Discovery Reappoints Dr. Larry Green as Chief Executive Officer
23 Sep 2022 //
BUSINESSWIRE
Ablexis & AlivaMab Discovery Services Announce Agreements with Almirall
31 Jan 2022 //
BUSINESSWIRE
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva
14 Sep 2021 //
BUSINESSWIRE